Beyond BRAF: Where Next for Melanoma Therapy?

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2014.476
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2015English

Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma

Dermatology Research and Practice
Dermatology
2012English

Systemic Therapy for Previously Untreated Advanced BRAF-mutated Melanoma: Navigating a Shifting Landscape

Immunotherapy
OncologyAllergyImmunology
2017English

Development of Encorafenib for BRAF-mutated Advanced Melanoma

Current Opinion in Oncology
Cancer ResearchOncology
2018English

Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Discordancy in BRAF Mutations Among Primary and Metastatic Melanoma Lesions: Clinical Implications for Targeted Therapy

Modern Pathology
Forensic MedicinePathology
2014English

BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2014English

Where Next for Long-Term Care?

Political Quarterly
SociologyPolitical Science
2017English

Pharmacy Interventions - Where Now, Where Next?

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy